Distribution of endogenous tumour necrosis factor alpha in gliomas
- PMID: 9306934
- PMCID: PMC500050
- DOI: 10.1136/jcp.50.7.559
Distribution of endogenous tumour necrosis factor alpha in gliomas
Abstract
Aims: To determine the distribution and cellular origin of endogenous tumour necrosis factor alpha (TNF alpha) in the cellular components of human gliomas.
Methods: Frozen sections of 26 gliomas (four astrocytomas (As); two oligoastrocytomas (OA); one ansplastic astrocytoma (AA); one anaplastic oligoastrocytoma (AOA); 18 glioblastomas (GB)) were examined immunohistochemically using antihuman TNF alpha and anti-Leu-M5 (CD11c) antibodies. Additional studies with double immunohistocchemical procedures were performed with anti-glial fibrillary acidic protein and anti-neurofilament antibodies.
Results: Eighty per cent of the AA, AOA, and GB (16 of 20) had a positive reaction for TNF alpha, but only 17% of As and OA (one of six) were positive. Positive cells were seen in both the tumour tissue and adjacent brain tissues. TNF alpha protein was detected not only in the tumour cells but also in the endothelium of tumour vessels as well as reactive astrocytes and neurons.
Conclusions: Endogenous TNF alpha is present in cells of various origins in glial tumours including tumour vessels; however, the role of TNF alpha may be different in different types of cells or altered microenvironment.
Similar articles
-
Cellular targets of exogenous tumour necrosis factor-alpha (TNF alpha) in human gliomas.Acta Neurochir (Wien). 1996;138(12):1437-41. doi: 10.1007/BF01411123. Acta Neurochir (Wien). 1996. PMID: 9030351
-
Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas.J Neurooncol. 2001 May;53(1):13-20. doi: 10.1023/a:1011874800612. J Neurooncol. 2001. PMID: 11678425
-
Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas.Mod Pathol. 2000 Jan;13(1):56-67. doi: 10.1038/modpathol.3880010. Mod Pathol. 2000. PMID: 10658911
-
Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes.J Neurosurg. 1995 Aug;83(2):291-7. doi: 10.3171/jns.1995.83.2.0291. J Neurosurg. 1995. PMID: 7616275
-
Pathologic analysis of primary brain tumors.Neurol Clin. 1985 Nov;3(4):711-28. Neurol Clin. 1985. PMID: 3001488 Review.
Cited by
-
The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Biomolecules. 2017 Mar 27;7(2):34. doi: 10.3390/biom7020034. Biomolecules. 2017. PMID: 28346397 Free PMC article. Review.
-
MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.Oncogene. 2017 Aug 31;36(35):5006-5022. doi: 10.1038/onc.2017.129. Epub 2017 May 1. Oncogene. 2017. PMID: 28459461
-
p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells.J Neurooncol. 2012 Aug;109(1):35-44. doi: 10.1007/s11060-012-0875-7. Epub 2012 Apr 19. J Neurooncol. 2012. PMID: 22528800
-
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1. Cell Mol Biol Lett. 2022. PMID: 35109786 Free PMC article. Review.
-
Mechanisms of angiogenesis in gliomas.J Neurooncol. 2006 Jul;78(3):281-93. doi: 10.1007/s11060-005-9097-6. Epub 2006 Mar 23. J Neurooncol. 2006. PMID: 16554966 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials